Latest Regulatory Approvals News

Proteomics International has validated its PromarkerEndo blood test as a highly accurate, non-invasive diagnostic tool for endometriosis, with commercial launch planned in Australia for Q3 2025. The test promises to reduce the average seven-year diagnostic delay by providing a simple risk score applicable across all disease stages.

Orbminco Limited has entered a binding agreement to acquire the Majestic North Gold Project in Western Australia, boasting a JORC-compliant resource of nearly 40,000 ounces of gold. The company is raising A$0.88 million to support due diligence and exploration activities.

Zenith Minerals has secured a binding agreement to sell its 20% stake in Turkey’s Kavaklitepe Gold Project for US$543,000, marking a strategic shift to focus on its Australian gold assets.

Catalyst Metals Limited has secured A$150 million in equity to fund organic growth and exploration across its flagship Plutonic Gold Belt and Bendigo Gold Belt projects. The company aims to nearly double gold production to around 200,000 ounces per annum while reducing costs through strategic acquisitions and infrastructure leverage.

MA Financial Group is set to acquire Melbourne-based IP Generation, adding $2 billion in assets and boosting its real estate management platform to over $12 billion AUM. The deal is expected to enhance earnings in FY25 and deepen MA’s presence in the retail real estate sector.

EQ Resources Limited has successfully raised $18.8 million through a share placement, complemented by a $3 million Share Purchase Plan, to fund its tungsten mining projects and reduce debt.

The ACCC has decided not to oppose Insurance Australia Group’s proposed acquisition of RACQ Insurance, finding that competition in Queensland’s motor and home contents insurance markets remains robust despite the deal.

OD6 Metals has secured regulatory approval to launch an 18-hole, 5,000-metre drilling program at its Gulf Creek Copper Project, targeting promising repeat mineral structures. A further 7-hole deep drilling phase awaits approval, potentially expanding exploration near historic high-grade copper zones.

Hutchison Telecommunications (Amsterdam) B.V. has announced an off-market takeover bid for the 12.13% of Hutchison Telecommunications (Australia) Limited shares it does not already own, offering a 52.4% premium. The move aims to consolidate full ownership of the Australian telecom operator.

Zelira Therapeutics has published full results from a Phase I study showing its cannabinoid-based therapy ZLT-L-007 significantly outperforms Lyrica® in managing diabetic neuropathy pain and related symptoms.

Lincoln Minerals’ Kookaburra Graphite Project has delivered battery-grade graphite purity exceeding 99.95%, confirming its suitability for lithium-ion battery anodes through a safer, hydrofluoric acid-free process.

Argenica Therapeutics has expanded its intellectual property with a new US patent targeting surgically induced strokes, enhancing the commercial potential of its lead drug candidate ARG-007.